CClinicalTrials.gg
Status unknownNCT03992807Updated Mar 3, 2020

A Decision Aid for Patients With Age-related Cataract

An interventional study of A patient decision aid and A usual education booklet in Age-related Cataract, sponsored by Sun Yat-sen University. Status unknown at 1 site in China. Open to participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-03-03.

Sponsored by Sun Yat-sen University · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Mar 2020), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
773
Allocation
Randomized
Ages
50 Years to 80 Years
Sex
All
01

Study summary

To determine whether a decision aid increases informed decision about cataract surgery for patients with age-related cataract.

Read the detailed description

The need for cataract surgery is on the rise globally due to the aging population and high demands for greater visual functioning. Patients with age-related cataract face their initial decision about when to undergo cataract surgery. Although the majority of patients want to participate in a shared decision-making process, no decision aid has been available to improve the quality of decision. The purpose of this study is to determine whether a decision aid increases informed decision about cataract surgery for patients with age-related cataract.

02

Conditions studied

  • Age-related Cataract

Browse trials for

03

In context

Cataract

1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.

This study's enrollment of 773 is above the median of 80 across 1,155 interventional studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

Sun Yat-sen University is the lead sponsor of 1,644 studies on the registry; 602 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Individuals aged 50-80 years who have been resident in the selected study district for more than six months;
  2. A definite diagnosis of age-related cataract;
  3. Having not received cataract surgery;
  4. Willing to participate in the study and provide informed content.

Exclusion criteria

Exclusion criteria

  1. Bilateral blindness (presenting distance visual acuity worse than 3/60);
  2. Having ocular, hearing or mental disorder precluding reading or telephone interview;
  3. Ocular disorders other than cataract leading to permanent vision loss that could not be corrected through cataract surgery;
  4. Having cataract surgery contraindication.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
773 participants (actual)

Study arms

  • Experimental
    A patient decision aid

    A patient decision aid that includes not only the standard general information, but also the quantitative risk information on the possible outcomes of cataract surgery as well as value clarification exercise.

    Other: A patient decision aid

  • Active comparator
    A usual education booklet

    A traditional booklet with standard general information developed by the National Eye Institute (NEI) to help patients understand cataract.

    Other: A usual education booklet

Interventions

  • OtherA patient decision aid

    Potential participants receive a printed decision aid booklet with information about cataract surgery choice, and outcome data will be gathered using standardized questions in a structured interview after 2 weeks and 1 year.

  • OtherA usual education booklet

    Potential participants receive a usual booklet about cataract and cataract surgery, and outcome data will be gathered using standardized questions in a structured interview after 2 weeks and 1 year.

06

What researchers measure

Primary outcomes

  1. Informed choice about cataract surgery (the proportion of participants who make an informed choice,which is defined as a good knowledge score and an intention that is consistent with their attitude score)

    Informed choice is an aggregated measure of multiple measurements, including knowledge (a 12-item questionnaire that assesses conceptual (items 1-10) and numerical (items 11-12) knowledge), attitudes (6 items, with 5 responses for each), and intentions (single item with 5 responses) Analysis: Informed Choice= Good Knowledge (score ≥50% in basic knowledge, ≥40% in knowledge associated with each treatment option, and at least 1 point in each numerical knowledge question) AND Positive Attitude (score ≥24) AND Positive Intention ("definitely will" or "likely to"), OR Good Knowledge AND Negative Attitude (score \<23) AND Negative Intention ("unsure", "not likely to", or "definitely will not")

    Time frame: 2 weeks post intervention

Secondary outcomes

  1. Perceived importance of surgical benefit/harms

    Purpose-developed items will be used to ask participants about their personal perceptions of the importance of specific outcomes in their decision-making about cataract surgery.

    Time frame: 2 weeks post intervention

  2. Perceived personal chances of surgical benefit/harms

    Participants will be asked about their perceived personal likelihood of experiencing specific outcomes if they have cataract surgeries, compared with an average patient who had undergone cataract surgery.

    Time frame: 2 weeks post intervention

  3. Decisional conflict

    Decisional conflict will be assessed using a 16-item Decisional Conflict Scale.

    Time frame: 2 weeks post intervention

  4. Decisional confidence

    Decisional confidence will be assessed using a 11-item Decision Self Efficacy Scale.

    Time frame: 2 weeks post intervention

  5. Time perspective

    This will be assessed using a 4-item short form of the Consideration of Future Consequences Scale, with five response categories ranging from strongly agree to strongly disagree.

    Time frame: 2 weeks post intervention

  6. Anticipated regret

    Two items from a validated scale will measure anticipated regret about having cataract surgery (action regret) and about not having cataract (inaction regret).

    Time frame: 2 weeks post intervention

  7. Cataract worry and anxiety

    A validated single item will measure participants' level of worry about progression of cataract, using four verbal response categories ranging from not worried at all to very worried. Anxiety will be measured with a six-item short form.

    Time frame: 2 weeks post intervention

  8. Booklet utilization and acceptability

    Acceptability and utilization of materials will be assessed based on the following items: 1. the proportion of participants who could read the booklet all the way through; 2. the proportion of participants who agree that the information is new; 3. the proportion of participants who agree that the length is just about right; 4. the proportion of participants who think the information is balanced; 5. the proportion of participants who agree that the booklet is clear and easy to understand; 6. the proportion of participants who find the materials helpful; 7. the proportion of participants who feel it worth recommending to others.

    Time frame: 2 weeks post intervention

  9. Undergoing cataract surgery

    Self-reported undergoing cataract surgery will be assessed via telephone survey at 1 year.

    Time frame: 1 year post intervention

  10. Decision regret

    The Decision Regret Scale will measure participants' level of regret regarding their initial decision whether to have cataract surgery or not.

    Time frame: 1 year post intervention

  11. Visual functioning

    This will be assessed using the Catquest 9SF questionnaire.

    Time frame: Baseline, 1 year post intervention

  12. Fall questionnaire

    This will be assessed using a single item question "Did you have any fall in the past 12 months whereby you landed on the ground or floor?"

    Time frame: 1 year post intervention

  13. Heath-related quality of life: Chinese version of the EQ-5D-5L telephone interview script

    This will be assessed using the simplified Chinese version of the EQ-5D-5L telephone interview script from the EuroQol research foundation.

    Time frame: Baseline, 1 year post intervention

  14. Costs

    This will be assessed using the Treatment Inventory of Costs in Patients with psychiatric disorders (TIC-P) questionnaire.

    Time frame: Baseline, 1 year post intervention

07

Study locations

1 site
  • Zhognshan Ophthalmic Center, Sun Yat-sen University
    Guangzhou, Guangdong 510000, China
08

References and documents

Publications

  • Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Silvester A, Stevens GA, Tahhan N, Wong TY, Taylor HR; Vision Loss Expert Group of the Global Burden of Disease Study. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017 Dec;5(12):e1221-e1234. doi: 10.1016/S2214-109X(17)30393-5. Epub 2017 Oct 11. PubMed 29032195 ↗
  • Kessel L, Andresen J, Erngaard D, Flesner P, Tendal B, Hjortdal J. Indication for cataract surgery. Do we have evidence of who will benefit from surgery? A systematic review and meta-analysis. Acta Ophthalmol. 2016 Feb;94(1):10-20. doi: 10.1111/aos.12758. Epub 2015 Jun 3. PubMed 26036605 ↗
  • McCarty CA, Keeffe JE, Taylor HR. The need for cataract surgery: projections based on lens opacity, visual acuity, and personal concern. Br J Ophthalmol. 1999 Jan;83(1):62-5. doi: 10.1136/bjo.83.1.62. PubMed 10209437 ↗
  • Zheng Y, Qu B, Jin L, Wang C, Zhong Y, He M, Liu Y. Patient-centred and economic effectiveness of a decision aid for patients with age-related cataract in China: study protocol of a randomised controlled trial. BMJ Open. 2020 May 18;10(5):e032242. doi: 10.1136/bmjopen-2019-032242. PubMed 32430445 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 3, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03992807
Lead sponsor
Sun Yat-sen University
Responsible party
Yingfeng Zheng (Principal Investigator, Sun Yat-sen University) — Principal investigator
First posted
Jun 20, 2019
Start date
Jul 1, 2019
Primary completion
Nov 12, 2019
Completion
Nov 12, 2020 (estimated)
Last update
Mar 3, 2020

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion